Render Target: SSR
Render Timestamp:
4/1/2025, 11:44:15 AM EDT
4/1/2025, 3:44:15 PM UTC
Commit: 461ca8d8fe5b1efd4c01fc87e5b5eb592e2d154a
XML generation date: 2025-03-25 22:05:23.441
Product last modified at: 2025-03-27T08:00:12.050Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

RPL19 (F9Z9N) Rabbit mAb #94730

Filter:
  • WB

    Supporting Data

    REACTIVITY H M R Mk
    SENSITIVITY Endogenous
    MW (kDa) 25
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    RPL19 (F9Z9N) Rabbit mAb recognizes endogenous levels of total RPL19 protein.

    Species Reactivity:

    Human, Mouse, Rat, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val55 of human RPL19 protein.

    Background

    Ribosomal protein L19 (RPL19) is part of the ribosomal large 60S subunit. It is conserved in eukaryotes and archaea but is not present in bacteria (1-3). Like many other ribosomal proteins, it is critically important in cellular function, and many RPL19 pseudogenes are present throughout the genome (4). RPL19 is co-amplified along with HER2 in breast cancer (5). When highly expressed, RPL19 has been shown to be a poor prognostic marker in prostate and colorectal cancers and has been identified as a novel tumor antigen in lung adenocarcinoma (6-8).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.